Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA neurology"
DOI: 10.1001/jamaneurol.2022.0489
Abstract: Importance Recent studies suggest that maintenance intravenous immunoglobulin (IVIG) may be an effective treatment to prevent relapses in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD); however, most of these studies had pediatric cohorts, and few studies… read more here.
Keywords: maintenance ivig; adult; maintenance; disease ... See more keywords
The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis.
Sign Up to like & getrecommendations! Published in 2022 at "Annals of clinical and translational neurology"
DOI: 10.1002/acn3.51540
Abstract: OBJECTIVE Although intravenous immunoglobulin (IVIG) is the first-line immunotherapy in autoimmune encephalitis, all supporting evidence comes from retrospective case series. Here, we performed a prospective clinical trial of IVIG for functional recovery in autoimmune encephalitis.… read more here.
Keywords: autoimmune encephalitis; day; encephalitis; efficacy ... See more keywords
Reply: Post‐COVID‐19 Myoclonus‐Ataxia Syndrome—Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?
Sign Up to like & getrecommendations! Published in 2023 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13693
Abstract: We thank Drs. Filip and Jarosław for their comment questioning the need for intravenous immunoglobulin (IVIG) for all cases of post-COVID-19 myoclonus-ataxia syndrome. The response to IVIG or steroids suggests indeed an autoimmune etiology, although… read more here.
Keywords: covid myoclonus; need intravenous; post covid; intravenous immunoglobulin ... See more keywords
Intravenous immunoglobulin (IVIg) therapy in hospitalised adult COVID‐19 patients: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "Reviews in Medical Virology"
DOI: 10.1002/rmv.2397
Abstract: Intravenous immunoglobulin (IVIg) therapy has been suggested as a potential treatment option for hospitalised COVID‐19 patients. The aim of this systematic review and meta‐analysis was to investigate the potential impact of IVIg on mortality and… read more here.
Keywords: meta analysis; covid patients; adult; therapy ... See more keywords
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
Sign Up to like & getrecommendations! Published in 2021 at "Neurotherapeutics"
DOI: 10.1007/s13311-021-01108-4
Abstract: In the last 25 years, intravenous immunoglobulin (IVIg) has had a major impact in the successful treatment of previously untreatable or poorly controlled autoimmune neurological disorders. Derived from thousands of healthy donors, IVIg contains IgG1… read more here.
Keywords: intravenous immunoglobulin; neurology; chronic therapy; ivig ... See more keywords
Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH?
Sign Up to like & getrecommendations! Published in 2020 at "Autoimmunity Reviews"
DOI: 10.1016/j.autrev.2020.102561
Abstract: Shoenfeld [1] postulates that in COVID-19 infected patients a clinical constellation of cytokine storm, respiratory failure and eventually death is reminiscent of a “hyperferritinemic syndrome” a condition that resembles a hemophagocytic lymphohistiocytosis (HLH)-like syndrome. One… read more here.
Keywords: ivig; infection; covid; cytotoxicity ... See more keywords
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience.
Sign Up to like & getrecommendations! Published in 2021 at "Autoimmunity reviews"
DOI: 10.1016/j.autrev.2021.102981
Abstract: INTRODUCTION Intravenous immunoglobulins (IVIG) are a new therapeutic approach in systemic sclerosis SSc. An immunomodulatory and antifibrotic activity has been postulated. IVIG are generally well tolerated and have only rare side effects. Our retrospective study… read more here.
Keywords: ssc; systemic sclerosis; skin involvement; ivig ... See more keywords
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.
Sign Up to like & getrecommendations! Published in 2019 at "Contemporary clinical trials"
DOI: 10.1016/j.cct.2019.02.008
Abstract: BACKGROUND Although intravenous immunoglobulin (IVIG) is effective therapy for Kawasaki disease (KD), the most common cause of acquired heart disease in children, 10-20% of patients are IVIG-resistant and require additional therapy. This group has an… read more here.
Keywords: intravenous immunoglobulin; trial; treatment; kawasaki disease ... See more keywords
Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia.
Sign Up to like & getrecommendations! Published in 2019 at "Cytokine"
DOI: 10.1016/j.cyto.2019.05.014
Abstract: Immune thrombocytopenia (ITP) is a common immune-mediated bleeding disorder in children, and intravenous immunoglobulin (IVIG) is widely used as the initial therapy of ITP. Effective predictive factors of response to IVIG in ITP are important… read more here.
Keywords: itp patients; ivig response; immune thrombocytopenia; ivig ... See more keywords
Eczematous reaction to IVIG for the treatment of dermatomyositis☆☆☆
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Women's Dermatology"
DOI: 10.1016/j.ijwd.2018.03.004
Abstract: The use of high-dose intravenous immunoglobulin (IVIG) is an accepted therapy for patients with refractory dermatomyositis. Cases of eczematous reactions to IVIG have been reported in the literature, but to our knowledge, none in patients… read more here.
Keywords: high dose; eczematous reaction; reaction ivig; ivig ... See more keywords
Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?
Sign Up to like & getrecommendations! Published in 2017 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2017.10.027
Abstract: Abstract Systemic administration of corticosteroid (CS) remains the standard gold treatment for pemphigus. However, because of several long‐term adverse effects, steroid‐sparing agents are usually prescribed in combination with CSs. Despite the high number of available… read more here.
Keywords: medicine; options pemphigus; treatment; ivig ... See more keywords